JP2017513937A5 - - Google Patents

Info

Publication number

JP2017513937A5

JP2017513937A5 JP2017504289A JP2017504289A JP2017513937A5 JP 2017513937 A5 JP2017513937 A5 JP 2017513937A5 JP 2017504289 A JP2017504289 A JP 2017504289A JP 2017504289 A JP2017504289 A JP 2017504289A JP 2017513937 A5 JP2017513937 A5 JP 2017513937A5

Authority

JP

Japan

Prior art keywords

seq

air marker

patient

antagonist

air

Prior art date

2015-04-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003550 marker Substances 0.000 claims description 74
• 238000000034 method Methods 0.000 claims description 56
• 239000005557 antagonist Substances 0.000 claims description 43
• 239000012472 biological sample Substances 0.000 claims description 17
• 208000006673 asthma Diseases 0.000 claims description 12
• 238000003556 assay Methods 0.000 claims description 10
• 238000004458 analytical method Methods 0.000 claims description 6
• 239000012634 fragment Substances 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
• 108091034117 Oligonucleotide Proteins 0.000 claims description 4
• 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
• 238000003752 polymerase chain reaction Methods 0.000 claims description 4
• 229920001184 polypeptide Polymers 0.000 claims description 4
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims description 4
• 238000003757 reverse transcription PCR Methods 0.000 claims description 4
• 238000000123 temperature gradient gel electrophoresis Methods 0.000 claims description 4
• 108700028369 Alleles Proteins 0.000 claims description 2
• 101710099953 DNA mismatch repair protein msh3 Proteins 0.000 claims description 2
• 238000002965 ELISA Methods 0.000 claims description 2
• 102000003960 Ligases Human genes 0.000 claims description 2
• 108090000364 Ligases Proteins 0.000 claims description 2
• 238000000636 Northern blotting Methods 0.000 claims description 2
• 238000002105 Southern blotting Methods 0.000 claims description 2
• 239000000427 antigen Substances 0.000 claims description 2
• 102000036639 antigens Human genes 0.000 claims description 2
• 108091007433 antigens Proteins 0.000 claims description 2
• 230000005540 biological transmission Effects 0.000 claims description 2
• 210000004369 blood Anatomy 0.000 claims description 2
• 239000008280 blood Substances 0.000 claims description 2
• 238000005251 capillar electrophoresis Methods 0.000 claims description 2
• 238000000684 flow cytometry Methods 0.000 claims description 2
• 238000009396 hybridization Methods 0.000 claims description 2
• 238000003018 immunoassay Methods 0.000 claims description 2
• 238000003364 immunohistochemistry Methods 0.000 claims description 2
• 238000001727 in vivo Methods 0.000 claims description 2
• 238000002844 melting Methods 0.000 claims description 2
• 230000008018 melting Effects 0.000 claims description 2
• 108020004707 nucleic acids Proteins 0.000 claims description 2
• 102000039446 nucleic acids Human genes 0.000 claims description 2
• 150000007523 nucleic acids Chemical class 0.000 claims description 2
• 210000002381 plasma Anatomy 0.000 claims description 2
• 238000002731 protein assay Methods 0.000 claims description 2
• 230000004043 responsiveness Effects 0.000 claims description 2
• 210000003296 saliva Anatomy 0.000 claims description 2
• 239000000523 sample Substances 0.000 claims description 2
• 238000012163 sequencing technique Methods 0.000 claims description 2
• 210000002966 serum Anatomy 0.000 claims description 2
• 210000001138 tear Anatomy 0.000 claims description 2
• 210000001519 tissue Anatomy 0.000 claims description 2
• 210000002700 urine Anatomy 0.000 claims description 2
• 238000001262 western blot Methods 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 19
• 239000003814 drug Substances 0.000 claims 1
• 238000004949 mass spectrometry Methods 0.000 claims 1
• 239000000203 mixture Substances 0.000 claims 1
• 238000004587 chromatography analysis Methods 0.000 description 1